1st Quarter - Report

ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP

Firm
Client
Income
—
Expenses
$600,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and remimbursement Medicaid Coverage

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
HELEN DWIGHT New Rep.Susan Brooks;Leg.Director(2017),Leg.Asst(2015-16)/Sen.Cory Gardner;Policy Adv.(2014)/Rep.L.Lance;Leg.Asst(2013)/Rep.C.Bass(2011-12)/Sen.J.Gregg;Leg.Corr/Asst(2009-2011)/G.W.Bush Pres.Library;intern(2009)
MARIA FIRVIDA —
JULIE GARNER —
NATALIE MORRIS —
JOHN MYERS —
LAURA OKPALA —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

American Health Care Act (HR 1628 House) SYNC Act - Medication Adherence (House) Value of Prescription Drugs Chronic Care - Druge Adherence and Continuity of Care (S 870) Price Transparency Oncology Oncology Care Model - CMS Personalized Medicine Affordable and Safe Prescription Drug Importation Act - S 469 Cancer Care Payment Reform Act (S 463, H 1834) Innovative Payments Vaccines for Children program

LobbyistCovered position, as disclosed
CHRISTINE BLOOMQUIST —
HELEN DWIGHT New Rep.Susan Brooks;Leg.Director(2017),Leg.Asst(2015-16)/Sen.Cory Gardner;Policy Adv.(2014)/Rep.L.Lance;Leg.Asst(2013)/Rep.C.Bass(2011-12)/Sen.J.Gregg;Leg.Corr/Asst(2009-2011)/G.W.Bush Pres.Library;intern(2009)
MARIA FIRVIDA —
JULIE GARNER —
THERESA JOLIVETTE —
NATALIE MORRIS —
JOHN MYERS —
LAURA OKPALA —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1628 (115th)

Pharmacy PHA

Adherence & Medication Synchronization Bill/ SYNC Act - Medication Adherence (House) Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 (Senate S.870) Medicare Telehealth Parity Act (H.R. 2550) Electronic Prior Authorization Under Medicare Part D (House) Cardiac Bundled Payment Model (HHS/CMMI) Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House Price Transparency, Senate & House S. 251, Senate and House CDC Asthma Funding, Senate Legislative proposals to change Medicare Part D Medicaid and 340B issues

LobbyistCovered position, as disclosed
HELEN DWIGHT New Rep.Susan Brooks;Leg.Director(2017),Leg.Asst(2015-16)/Sen.Cory Gardner;Policy Adv.(2014)/Rep.L.Lance;Leg.Asst(2013)/Rep.C.Bass(2011-12)/Sen.J.Gregg;Leg.Corr/Asst(2009-2011)/G.W.Bush Pres.Library;intern(2009)
MARIA FIRVIDA —
THERESA JOLIVETTE —
NATALIE MORRIS —
JOHN MYERS —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Bills named: S. 251 (115th), S. 870 (115th), H.R. 2550 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.